{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:39:10Z","timestamp":1755794350536,"version":"3.44.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ijbiomac.2025.146198","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T23:14:23Z","timestamp":1753139663000},"page":"146198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Mycobacterium tuberculosis methyltransferases as alternative strategies to combat drug resistant tuberculosis"],"prefix":"10.1016","volume":"321","author":[{"given":"Kashish","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Tanweer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd Zaid","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonam","family":"Grover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.146198_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005349","article-title":"The genetic requirements for fast and slow growth in mycobacteria","volume":"4","author":"Beste","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0015","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1574-6976.2012.00331.x","article-title":"Mycobacterium tuberculosis: success through dormancy","volume":"36","author":"Gengenbacher","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0020","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tube.2017.08.005","article-title":"Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection","volume":"107","author":"Yang","year":"2017","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065202","article-title":"Tuberculosis: pathogenesis, current treatment regimens and new drug targets","volume":"24","author":"Alsayed","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01499","article-title":"Host antimicrobial peptides: the promise of new treatment strategies against tuberculosis","volume":"8","author":"Arranz-Trull\u00e9n","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2020.101574","article-title":"Drug resistant tuberculosis: a review","volume":"74","author":"Khawbung","year":"2021","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1183\/09031936.00134712","article-title":"Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes","volume":"42","author":"Falzon","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0045","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jgar.2020.02.029","article-title":"Potential strategies for the management of drug-resistant tuberculosis","volume":"22","author":"Sharma","year":"2020","journal-title":"J. Glob. Antimicrob. Resist"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0050","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1039\/C5MB00810G","article-title":"Analyses of methyltransferases across the pathogenicity spectrum of different mycobacterial species point to an extremophile connection","volume":"12","author":"Grover","year":"2016","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.622487","article-title":"The M. tuberculosis Rv1523 methyltransferase promotes drug resistance through methylation-mediated cell wall remodeling and modulates macrophages immune responses","volume":"11","author":"Ali","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0060","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M510250200","article-title":"Further insight into S-adenosylmethionine-dependent methyltransferases: structural characterization of hma, an enzyme essential for the biosynthesis of oxygenated mycolic acids in Mycobacterium tuberculosis","volume":"281","author":"Boissier","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0065","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3390\/app10062153","article-title":"Drug-resistant tuberculosis 2020: where we stand","volume":"10","author":"Iacobino","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0070","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.addr.2005.04.002","article-title":"Bacterial resistance to antibiotics: enzymatic degradation and modification","volume":"57","author":"Wright","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0075","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1606590113","article-title":"N -methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis","volume":"113","author":"Warrier","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.plipres.2012.05.002","article-title":"Towards understanding the functional diversity of cell wall mycolic acids of Mycobacterium tuberculosis","volume":"51","author":"Verschoor","year":"2012","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0085","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1021\/acs.chemrev.0c01226","article-title":"Physiological functions of bacterial \u201cmultidrug\u201d efflux pumps","volume":"121","author":"Henderson","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104108","article-title":"P-glycoprotein inhibitors as an adjunct therapy for TB","volume":"29","author":"Parida","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2017.00171","article-title":"Host-directed therapeutic strategies for tuberculosis","volume":"4","author":"Kolloli","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0100","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1164\/rccm.201001-0077OC","article-title":"Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis","volume":"182","author":"Van Deun","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0105","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1586\/14787210.4.5.759","article-title":"Antimicrobial resistance in tuberculosis: an international perspective","volume":"4","author":"van Helden","year":"2006","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0110","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tim.2016.03.007","article-title":"Antimicrobial resistance in Mycobacterium tuberculosis: the odd one out","volume":"24","author":"Eldholm","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2023.1314077","article-title":"Introduction to small molecule drug discovery and preclinical development","volume":"3","author":"Southey","year":"2023","journal-title":"Front. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0120","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021196","article-title":"Host-directed therapies for tuberculosis","volume":"5","author":"Tobin","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0125","first-page":"124","article-title":"Tumor necrosis factor neutralization combined with chemotherapy enhances Mycobacterium tuberculosis clearance and reduces lung pathology","volume":"2","author":"Bourigault","year":"2013","journal-title":"Am J Clin Exp Immunol"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.676456","article-title":"Mycobacterium tuberculosis phosphoribosyltransferase promotes bacterial survival in macrophages by inducing histone hypermethylation in autophagy-related genes","volume":"11","author":"Sengupta","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0135","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1586\/ecp.11.41","article-title":"Immunomodulation by vitamin D: implications for TB","volume":"4","author":"Chun","year":"2011","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0140","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"2003","key":"10.1016\/j.ijbiomac.2025.146198_bb0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2296-4-18","article-title":"Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials","volume":"4","author":"Edwards","year":"2003","journal-title":"BMC Fam. Pract."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0150","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0155","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/infdis\/jiz517","article-title":"Adjunctive host-directed therapy with statins improves tuberculosis-related outcomes in mice","volume":"221","author":"Dutta","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0160","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/infdis\/jit550","article-title":"Statin therapy reduces the Mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation","volume":"209","author":"Parihar","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0165","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.2174\/0929867325666180706101404","article-title":"Recent drug-repurposing-driven advances in the discovery of novel antibiotics","volume":"26","author":"Konreddy","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2229-516X.112228","article-title":"Bedaquiline: first FDA-approved tuberculosis drug in 40 years","volume":"3","author":"Mahajan","year":"2013","journal-title":"Int. J. Appl. Basic Med. Res."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0175","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa1112433","article-title":"Delamanid for multidrug-resistant pulmonary tuberculosis","volume":"366","author":"Gler","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0180","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/antibiotics12030590","article-title":"Perchlozone resistance in clinical isolates of Mycobacterium tuberculosis","volume":"12","author":"Ushtanit","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0185","article-title":"Safety, tolerability, pharmacokinetics, and metabolism of Telacebec (Q203) for the treatment of tuberculosis: a randomized, placebo-controlled, multiple ascending dose phase 1B trial","volume":"67","author":"Kim","year":"2022","journal-title":"AAC"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0190","doi-asserted-by":"crossref","first-page":"e01318","DOI":"10.1128\/aac.01318-24","article-title":"Real-time evaluation of macozinone activity against Mycobacterium tuberculosis through bacterial nanomotion analysis","volume":"69","author":"Vocat","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0195","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/thx.52.6.523","article-title":"Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma","volume":"52","author":"Barnes","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0200","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708038","article-title":"An allosteric inhibitor of Mycobacterium tuberculosis ArgJ: implications to a novel combinatorial therapy","volume":"10","author":"Mishra","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0205","doi-asserted-by":"crossref","first-page":"17362","DOI":"10.1021\/acsomega.2c05511","article-title":"Potential repurposed drug candidates for tuberculosis treatment: progress and update of drugs identified in over a decade","volume":"8","author":"Sharma","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0210","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/0971-5916.166599","article-title":"Efficacy of moxifloxacin & econazole against multidrug resistant (MDR) Mycobacterium tuberculosis in murine model","volume":"142","author":"Gupta","year":"2015","journal-title":"IJMR"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0215","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/jcm6030030","article-title":"Novel pharmacological activity of artesunate and artemisinin: their potential as anti-tubercular agents","volume":"6","author":"Choi","year":"2017","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0220","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijtb.2018.04.003","article-title":"Metformin induced autophagy in diabetes mellitus \u2013 tuberculosis co-infection patients: a case study","volume":"66","author":"Novita","year":"2019","journal-title":"Indian Journal of Tuberculosis"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.101902","article-title":"Potential role of adjuvant drugs on efficacy of first line oral antitubercular therapy: drug repurposing","volume":"120","author":"Mishra","year":"2020","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0235","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.biotechadv.2016.05.007","article-title":"Antimicrobial peptides as novel anti-tuberculosis therapeutics","volume":"34","author":"Silva","year":"2016","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/s11535-007-0010-5","article-title":"Antimicrobial peptides: an overview of a promising class of therapeutics","volume":"2","author":"Giuliani","year":"2007","journal-title":"Open Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0245","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2006.03.011","article-title":"Mechanisms of antimicrobial resistance in bacteria","volume":"119","author":"Tenover","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0250","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.biomaterials.2013.11.035","article-title":"Anti-mycobacterial activities of synthetic cationic \u03b1-helical peptides and their synergism with rifampicin","volume":"35","author":"Khara","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0255","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s10989-022-10435-9","article-title":"Role of antimicrobial peptides in treatment and prevention of Mycobacterium tuberculosis: a review","volume":"28","author":"Mehta","year":"2022","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12111071","article-title":"Antimicrobial peptide against Mycobacterium tuberculosis that activates autophagy is an effective treatment for tuberculosis","volume":"12","author":"Pel\u00e1ez Coyotl","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0265","doi-asserted-by":"crossref","DOI":"10.4110\/in.2020.20.e12","article-title":"Vitamin D-cathelicidin axis: at the crossroads between protective immunity and pathological inflammation during infection","volume":"20","author":"Chung","year":"2020","journal-title":"Immune Netw."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0270","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijmyco.2015.07.002","article-title":"Interaction of antimicrobial peptide with mycolyl transferase in Mycobacterium tuberculosis","volume":"5","author":"Banerjee","year":"2016","journal-title":"Int. J. Mycobacteriol"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0275","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.tube.2011.03.003","article-title":"Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin","volume":"91","author":"Sow","year":"2011","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0280","series-title":"Ethnopharmacological Investigation of Indian Spices","first-page":"205","article-title":"Nano approach: Indian spices as antimicrobial agents","author":"Chakravorty","year":"2020"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.mimet.2020.106127","article-title":"Nano-based drug delivery optimization for tuberculosis treatment: a review","volume":"181","author":"Dahanayake","year":"2021","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0290","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1208\/s12249-019-1334-y","article-title":"Ethambutol-loaded solid lipid nanoparticles as dry powder inhalable formulation for tuberculosis therapy","volume":"20","author":"Nemati","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0295","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jac\/dkg477","article-title":"Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis","volume":"52","author":"Pandey","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0300","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.addr.2009.11.023","article-title":"New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery","volume":"62","author":"Sosnik","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0305","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1128\/AAC.01164-06","article-title":"Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model","volume":"51","author":"Garcia-Contreras","year":"2007","journal-title":"AAC"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0310","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1128\/AAC.02346-12","article-title":"Phase I, single-dose, dose-escalating study of inhaled dry powder capreomycin: a new approach to therapy of drug-resistant tuberculosis","volume":"57","author":"Dharmadhikari","year":"2013","journal-title":"AAC"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/cells12162119","article-title":"Antisense therapy for infectious diseases","volume":"12","author":"Buthelezi","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0320","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0325","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1093\/nar\/gkv920","article-title":"The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA","volume":"43","author":"Vickers","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0330","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14304\/SURYA.JPR.V4N7.5","article-title":"RNA therapeutics: RNAi and antisense mechanisms and clinical applications","volume":"4","author":"Chery","year":"2016","journal-title":"Postdoc J"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0335","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1172\/JCI86799","article-title":"Welcome to the splice age: antisense oligonucleotide\u2013mediated exon skipping gains wider applicability","volume":"126","author":"McNally","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0340","series-title":"Exon Skipping: Methods and Protocols","first-page":"307","article-title":"Antisense-mediated exon inclusion","author":"Hua","year":"2012"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0345","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/nat.2022.0009","article-title":"Host-directed targeting of lincRNA-MIR99AHG suppresses intracellular growth of Mycobacterium tuberculosis","volume":"32","author":"Gcanga","year":"2022","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01049","article-title":"A new antisense phosphoryl guanidine oligo-2\u2032-O-methylribonucleotide penetrates into intracellular mycobacteria and suppresses target gene expression","volume":"10","author":"Skvortsova","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0360","series-title":"Mycobacterium tuberculosis","first-page":"101","article-title":"Mycobacterial methyltransferases: significance in pathogenesis and virulence","author":"Grover","year":"2019"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0365","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021113","article-title":"The mycobacterial cell wall\u2014peptidoglycan and arabinogalactan","volume":"5","author":"Alderwick","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0370","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/ncomms1878","article-title":"Genomics of DNA cytosine methylation in Escherichia coli reveals its role in stationary phase transcription","volume":"3","author":"Kahramanoglou","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0375","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/jb.148.2.716-719.1981","article-title":"Deoxyribonucleic acid methylation in mycobacteria","volume":"148","author":"Srivastava","year":"1981","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0380","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.dnarep.2011.03.007","article-title":"The ada operon of Mycobacterium tuberculosis encodes two DNA methyltransferases for inducible repair of DNA alkylation damage","volume":"10","author":"Yang","year":"2011","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0385","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1128\/JB.02298-12","article-title":"Biochemical and structural studies of the Mycobacterium tuberculosis O6-methylguanine methyltransferase and mutated variants","volume":"195","author":"Miggiano","year":"2013","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0390","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/BJ20150833","article-title":"Crystal structure of Mycobacterium tuberculosis O6-methylguanine-DNA methyltransferase protein clusters assembled on to damaged DNA","volume":"473","author":"Miggiano","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0395","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1021\/bi973113c","article-title":"Crystal structure of ErmC\u2032, an rRNA methyltransferase which mediates antibiotic resistance in bacteria","volume":"37","author":"Bussiere","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0400","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1006\/jmbi.2001.4935","article-title":"Crystal structure of Rv2118c: an AdoMet-dependent methyltransferase from Mycobacterium tuberculosis H37Rv1, 21This is CDRI communication no. 6159.2Edited by R. Huber","volume":"312","author":"Gupta","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0405","doi-asserted-by":"crossref","first-page":"19652","DOI":"10.1074\/jbc.M110.200428","article-title":"Structural and functional characterization of Rv2966c protein reveals an RsmD-like methyltransferase from Mycobacterium tuberculosis and the role of its N-terminal domain in target recognition *","volume":"286","author":"Kumar","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0410","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1107\/S1399004713033555","article-title":"The structure of Rv2372c identifies an RsmE-like methyltransferase from Mycobacterium tuberculosis","volume":"70","author":"Kumar","year":"2014","journal-title":"Acta Cryst D"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0415","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/AAC.48.1.143-150.2004","article-title":"Molecular basis of intrinsic macrolide resistance in the Mycobacterium tuberculosis complex","volume":"48","author":"Buri\u00e1nkov\u00e1","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0420","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.molcel.2006.05.044","article-title":"Capreomycin binds across the ribosomal subunit interface using tlyA-encoded 2\u2032-O-methylations in 16S and 23S rRNAs","volume":"23","author":"Johansen","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0425","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1128\/AAC.00905-13","article-title":"Functional role of methylation of G518 of the 16S rRNA 530 loop by GidB in Mycobacterium tuberculosis","volume":"57","author":"Wong","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0430","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.chembiol.2009.04.001","article-title":"Mycolic acid cyclopropanation is essential for viability, drug resistance, and cell wall integrity of Mycobacterium tuberculosis","volume":"16","author":"Barkan","year":"2009","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0435","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1099\/00221287-147-7-1825","article-title":"Separation and characterization of individual mycolic acids in representative mycobacteria","volume":"147","author":"Watanabe","year":"2001","journal-title":"Microbiology (Reading)"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0440","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0923-2508(91)90109-N","article-title":"Structure and stereochemistry of mycolic acids of Mycobacterium marinum and Mycobacterium ulcerans","volume":"142","author":"Daff\u00e9","year":"1991","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0445","doi-asserted-by":"crossref","first-page":"12196","DOI":"10.1016\/S0021-9258(18)33699-8","article-title":"Structures of the two homologous series of dialkene mycolic acids from Mycobacterium smegmatis","volume":"257","author":"Danielson","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0450","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0163-7827(98)00008-3","article-title":"Mycolic acids: structure, biosynthesis and physiological functions","volume":"37","author":"Barry","year":"1998","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0455","doi-asserted-by":"crossref","first-page":"14273","DOI":"10.1074\/jbc.275.19.14273","article-title":"Characterization of the heparin-binding site of the mycobacterial heparin-binding hemagglutinin adhesin","volume":"275","author":"Pethe","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0460","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tube.2018.10.009","article-title":"The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection","volume":"113","author":"Marimani","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0465","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/mr.55.3.451-458.1991","article-title":"DNA methylation and gene expression","volume":"55","author":"Razin","year":"1991","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1027394","article-title":"The evolving biology of Mycobacterium tuberculosis drug resistance","volume":"12","author":"Jones","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003419","article-title":"DNA methylation impacts gene expression and ensures hypoxic survival of Mycobacterium tuberculosis","volume":"9","author":"Shell","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0480","doi-asserted-by":"crossref","first-page":"8497","DOI":"10.1038\/s41467-023-43940-6","article-title":"The Mycobacterium tuberculosis methyltransferase Rv2067c manipulates host epigenetic programming to promote its own survival","volume":"14","author":"Singh","year":"2023","journal-title":"Nat. Commun."},{"author":"Dadireddy","key":"10.1016\/j.ijbiomac.2025.146198_bb0485"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0490","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.celrep.2015.04.004","article-title":"Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 di- and tri-methylation on target genes and transformation potential","volume":"11","author":"Kuntimaddi","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0495","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrmicro2387","article-title":"Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?","volume":"8","author":"Behar","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0505","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111801","article-title":"Epigenetic mechanisms induced by Mycobacterium tuberculosis to promote its survival in the host","volume":"25","author":"Thomas","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0510","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1093\/nar\/gkv261","article-title":"The interaction of mycobacterial protein Rv2966c with host chromatin is mediated through non-CpG methylation and histone H3\/H4 binding","volume":"43","author":"Sharma","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104778","article-title":"Mycobacterium tuberculosis Rv1515c antigen enhances survival of M. smegmatis within macrophages by disrupting the host defence","volume":"153","author":"Yang","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0520","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.906387","article-title":"Mycobacterium tuberculosis methyltransferase Rv1515c can suppress host defense mechanisms by modulating immune functions utilizing a multipronged mechanism","volume":"9","author":"Rani","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0525","doi-asserted-by":"crossref","unstructured":"S. Khosla, G. Sharma, I. Yaseen, Learning epigenetic regulation from mycobacteria, Microb Cell 3 (n.d.) 92\u201394. doi:10.15698\/mic2016.02.480.","DOI":"10.15698\/mic2016.02.480"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0530","doi-asserted-by":"crossref","first-page":"8922","DOI":"10.1038\/ncomms9922","article-title":"Mycobacteria modulate host epigenetic machinery by Rv1988 methylation of a non-tail arginine of histone H3","volume":"6","author":"Yaseen","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0535","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1006\/jmbi.2001.4935","article-title":"Crystal structure of Rv2118c: an AdoMet-dependent methyltransferase from Mycobacterium tuberculosis H37Rv1, 2","volume":"312","author":"Gupta","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0540","doi-asserted-by":"crossref","unstructured":"Nazim, T., Kumar, V., Ahmed, F., Ehtesham, N.Z., Hasnain, S.E., Sundar, D., Grover, S. Investigating the interaction pattern of FDA approved compounds with Mycobacterium tuberculosis GidB to understand their potential as antibiotics. J. Biomol. Struct. Dyn., 0(n.d.) 1-10. https:\/\/doi.org\/10.1080\/07391102.2024.2434026.","DOI":"10.1080\/07391102.2024.2434026"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0550","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2217\/fmb.13.113","article-title":"Vitamin B12 metabolism in Mycobacterium tuberculosis","volume":"8","author":"Gopinath","year":"2013","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127208","article-title":"Atosiban and Rutin exhibit anti-mycobacterial activity - an integrated computational and biophysical insight toward drug repurposing strategy against Mycobacterium tuberculosis targeting its essential enzyme HemD","volume":"253","author":"Sharma","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0560","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2958.2003.03425.x","article-title":"Genes required for mycobacterial growth defined by high density mutagenesis","volume":"48","author":"Sassetti","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0570","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2120352119","article-title":"50S subunit recognition and modification by the Mycobacterium tuberculosis ribosomal RNA methyltransferase TlyA","volume":"119","author":"Laughlin","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0575","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1261\/rna.057257.116","article-title":"Nonmutational compensation of the fitness cost of antibiotic resistance in mycobacteria by overexpression of tlyA rRNA methylase","volume":"22","author":"Freihofer","year":"2016","journal-title":"RNA"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0585","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1365-2958.2012.08168.x","article-title":"Capreomycin susceptibility is increased by TlyA-directed 2\u2032-O-methylation on both ribosomal subunits","volume":"85","author":"Monshupanee","year":"2012","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0590","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jmgm.2019.05.016","article-title":"Free enzyme dynamics of CmaA3 and CmaA2 cyclopropane mycolic acid synthases from Mycobacterium tuberculosis: insights into residues with potential significance in cyclopropanation","volume":"91","author":"Annaraj","year":"2019","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0595","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1016\/j.apsb.2022.04.014","article-title":"Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis","volume":"12","author":"Kuang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0600","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.micpath.2015.09.008","article-title":"RNA modification enzymes encoded by the gid operon: implications in biology and virulence of bacteria","volume":"89","author":"Shippy","year":"2015","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0605","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1093\/jac\/dku273","article-title":"Evaluation of gidB alterations responsible for streptomycin resistance in Mycobacterium tuberculosis","volume":"69","author":"Verma","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0615","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/jac\/46.3.391","article-title":"Intrinsic resistance of Mycobacterium tuberculosis to clarithromycin is effectively reversed by subinhibitory concentrations of cell wall inhibitors","volume":"46","author":"Bosne-David","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0620","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1128\/AAC.43.12.2823","article-title":"Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants","volume":"43","author":"Roberts","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0625","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.39.3.577","article-title":"Erythromycin resistance by ribosome modification","volume":"39","author":"Weisblum","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0630","doi-asserted-by":"crossref","first-page":"12702","DOI":"10.1016\/S0021-9258(17)44232-3","article-title":"Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics","volume":"258","author":"Skinner","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0635","doi-asserted-by":"crossref","first-page":"38942","DOI":"10.1074\/jbc.M505727200","article-title":"Methyltransferase Erm(37) slips on rRNA to confer atypical resistance in Mycobacterium tuberculosis*","volume":"280","author":"Madsen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0640","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1128\/AAC.46.6.1629-1633.2002","article-title":"Activity of the ketolide telithromycin is refractory to Erm monomethylation of bacterial rRNA","volume":"46","author":"Liu","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0645","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1128\/AAC.49.4.1447-1454.2005","article-title":"In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis","volume":"49","author":"Falzari","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0650","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1128\/AAC.44.10.2848-2852.2000","article-title":"In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4","volume":"44","author":"Rastogi","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0660","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1365-2958.2009.06604.x","article-title":"Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis","volume":"71","author":"Alahari","year":"2009","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0665","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001343","article-title":"Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria","volume":"2","author":"Alahari","year":"2007","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0670","doi-asserted-by":"crossref","first-page":"28326","DOI":"10.1074\/jbc.M003744200","article-title":"Activation of the pro-drug ethionamide is regulated in mycobacteria *","volume":"275","author":"Baulard","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0675","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3390\/antibiotics10111323","article-title":"The mycobacterial DNA methyltransferase HsdM decreases intrinsic isoniazid susceptibility","volume":"10","author":"Hu","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0680","article-title":"DNA methyltransferase HsdM induce drug resistance on Mycobacterium tuberculosis via multiple effects","volume":"10","author":"Chu","year":"2021","journal-title":"J. Antibiot."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0685","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1021\/bi201539j","article-title":"Control of substrate specificity by a single active site residue of the KsgA methyltransferase","volume":"51","author":"O'Farrell","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0690","first-page":"151","article-title":"Phylogenetic analysis of rRNA methyltransferases, Erm and KsgA, as related to antibiotic resistance","volume":"309","author":"Park","year":"2010","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0695","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijantimicag.2013.02.011","article-title":"A role for 16S rRNA dimethyltransferase (ksgA) in intrinsic clarithromycin resistance in Mycobacterium tuberculosis","volume":"41","author":"Phunpruch","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0700","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017863","article-title":"Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis","volume":"5","author":"Seung","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0705","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics12010067","article-title":"Current promising strategies against antibiotic-resistant bacterial infections","volume":"12","author":"Ye","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0710","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.trsl.2020.03.007","article-title":"New tuberculosis drug targets, their inhibitors, and potential therapeutic impact","volume":"220","author":"Shetye","year":"2020","journal-title":"Transl. Res."},{"issue":"2023","key":"10.1016\/j.ijbiomac.2025.146198_bb0715","first-page":"e353","article-title":"Mycobacterium tuberculosis: pathogenesis and therapeutic targets","volume":"4","author":"Yang","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0725","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/ijms13010427","article-title":"Adaptation of high-throughput screening in drug discovery\u2014toxicological screening tests","volume":"13","author":"Szyma\u0144ski","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.146198_bb0735","first-page":"53","article-title":"Molecular biology of drug resistance in Mycobacterium tuberculosis","volume":"374","author":"Smith","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025067558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025067558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T16:13:01Z","timestamp":1755274381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025067558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":136,"alternative-id":["S0141813025067558"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146198","relation":{},"ISSN":["0141-8130"],"issn-type":[{"type":"print","value":"0141-8130"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycobacterium tuberculosis methyltransferases as alternative strategies to combat drug resistant tuberculosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"146198"}}